分析不同暴露因素发现佩戴口罩和设立COVID-19区域可降低养老院续发感染风险
该研究分析了2020年3月至5月12家养老院(ACFs)的COVID-19暴发,使用RT-PCR和血清学检测,采用最大似然法和广义线性混合模型估计续发感染风险并识别相关协变量。续发感染风险估计为4.1%,提示该地区实施的感染预防与控制(IPC)措施效率较高;佩戴口罩和为感染者设立COVID-19区域是与较低续发感染风险相关的两个主要协变量。结论认为佩戴口罩和隔离潜在感染者似乎与SARS-CoV-2在养老院中更有限的传播相关。
要点
- 12家养老院COVID-19暴发的续发感染风险估计为4.1%。
- 佩戴口罩和为感染者设立COVID-19区域是与较低续发感染风险相关的两个主要协变量。
- 佩戴口罩和隔离潜在感染者似乎与SARS-CoV-2在养老院中更有限的传播相关。
核心结论
- 佩戴口罩和隔离潜在感染者似乎与SARS-CoV-2在养老院中更有限的传播相关。
研究设计与样本
- 分析2020年3月至5月12家养老院(ACFs)发生的COVID-19暴发,使用逆转录聚合酶链反应(RT-PCR)和血清学检测SARS-CoV-2感染。
- 采用最大似然法和广义线性混合模型分析养老院居民感染比例并识别与感染比例相关的协变量。
主要发现
- 续发感染风险估计为4.1%,提示该地区实施的感染预防与控制(IPC)措施效率较高。
- 佩戴口罩和为感染者设立COVID-19区域是与较低续发感染风险相关的两个主要协变量。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The COVID-19 epidemic has spread rapidly within aged-care facilities (ACFs), where the infection-fatality ratio is high. It is therefore urgent to evaluate the efficiency of infection prevention and control (IPC) measures in reducing SARS-CoV-2 transmission. METHODS: We analysed the COVID-19 outbreaks that took place between March and May 2020 in 12 ACFs using reverse transcription-polymerase chain reaction (RT-PCR) and serological tests for SARS-CoV-2 infection. Using maximum-likelihood approaches and generalized linear mixed models, we analysed the proportion of infected residents in ACFs and identified covariates associated with the proportion of infected residents. RESULTS: The secondary-attack risk was estimated at 4.1%, suggesting a high efficiency of the IPC measures implemented in the region. Mask wearing and the establishment of COVID-19 zones for infected residents were the two main covariates associated with lower secondary-attack risks. CONCLUSIONS: Wearing masks and isolating potentially infected residents appear to be associated with a more limited spread of SARS-CoV-2 in ACFs.
引用
- Reyné B, Selinger C, Sofonea MT, et al. Analysing different exposures identifies that wearing masks and establishing COVID-19 areas reduce secondary-attack risk in aged-care facilities. Int J Epidemiol. 2021. PMID: 34999872. doi:10.1093/ije/dyab121
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。